Investor News
Business
Cannabis
Medical
Mining
Search
Trader Alert
Investor News
Thursday, May 9, 2024
Trader Alert
Investor News
Investor News
Business
Cannabis
Medical
Mining
Search
Home
ZLDPF
ZLDPF
Breaking News
Zealand Pharma announces Boehringer Ingelheim survodutide Phase 2 trial shows 83% of adults treated achieved groundbreaking results in liver disease due to MASH, with...
editor
-
February 26, 2024
No posts to display
- Advertisment -
Most Read
Pop Culture Announces Improvement in Overall Operations During the Six Months Ended December 31, 2023
May 9, 2024
Epazz plans to spin off Galaxy Batteries Inc.
May 8, 2024
US Companies Moving the Markets, Morning edition Wed, May 08, 2024 as of 10.00 am ET
May 8, 2024
AURI Presents a Share Reduction Buy-Back and Uplisting Program
May 8, 2024